会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 신규 세라마이드 유도체, 이의 제조방법 및 이의 용도
    • 新型CERAMIDE衍生物,其制备方法和用途
    • KR1020050029785A
    • 2005-03-29
    • KR1020030065991
    • 2003-09-23
    • 주식회사 바이오씨에스노정래신종헌가톨릭대학교 산학협력단
    • 신종헌노정래김태윤김혜정
    • C07C235/28
    • Provided are a ceramide derivative which promotes apoptosis, its preparation method, and a cosmetic composition and a pharmaceutical composition for the treatment of skin disease or cancer containing the derivative or its salt. The ceramide derivative is represented by the formula 2, wherein R1 is H or a C1-C14 alkyl group; R2 is H, a hydroxyl group or a C1-C11 alkyl group; R3 is a 6-methyl-pentadeca-1,5,7-triene group, a 1-hydroxy-nonadeca-11-ene group or a nonadeca-1,11-diene group; and R4 is H or a C1-C6 alkoxy group. The method comprises the steps of extracting a starfish with an organic solvent; concentrating the extract under reduced pressure and fractionating the concentrated one with a solvent mixture of methanol and hexane according to polarity to obtain an active fraction; and separating and purifying the active fraction by chromatography. Preferably the starfish is Distolasterias nipon.
    • 提供促进细胞凋亡的神经酰胺衍生物,其制备方法和化妆品组合物和用于治疗皮肤病或含有衍生物或其盐的癌症的药物组合物。 神经酰胺衍生物由式2表示,其中R 1是H或C 1 -C 14烷基; R2是H,羟基或C1-C11烷基; R3是6-甲基 - 十五碳-5,7-三烯基,1-羟基 - 十九碳十一烯-11-烯基或十五碳-1,11-二烯基; R4为H或C1-C6烷氧基。 该方法包括用有机溶剂萃取海星的步骤; 在减压下浓缩提取物,并用甲醇和己烷的溶剂混合物根据极性对浓缩物进行分级,得到活性级分; 并通过色谱法分离和纯化活性级分。 海星最好是杜鹃花。
    • 6. 发明公开
    • 사가퀴노익산을 함유하는 피부질환 및 피부암의 예방 또는치료용 약학적 조성물
    • 含有SARGAQUICOIC酸的药物组合物,用于预防或治疗皮肤疾病和皮肤癌
    • KR1020070107252A
    • 2007-11-07
    • KR1020060039496
    • 2006-05-02
    • 가톨릭대학교 산학협력단
    • 김태윤신종헌이봉호신동헌
    • A61K31/192A61P17/00
    • A pharmaceutical composition containing Sargaquinoic acid for preventing or treating skin disease and skin cancer is provided to prevent and treat diseases associated with hyperplastic skin cells by inducing cytotoxicity and apoptosis of skin cells, and promotes apoptosis by irradiating ultraviolet rays. A pharmaceutical composition for preventing or treating skin disease and skin cancer contains Sargaquinoic acid represented by the formula(I) or its pharmaceutically acceptable salt as an effective ingredient, wherein the medicinal effects of the pharmaceutical composition are increased by irradiating ultraviolet rays and the skin disease is hyperplastic skin disease including psoriasis, fishskin disease, Bowen's disease, papilloma, eczema, eczema, atopic dermatitis, acne vulgaris, dermatitis, lichen planus, striatus, foot hyperkeratosis, dark spots, actinic keratosis, skin aging and photoaging.
    • 提供含有用于预防或治疗皮肤病和皮肤癌的夸喹酸的药物组合物,通过诱导皮肤细胞的细胞毒性和凋亡来预防和治疗与增生性皮肤细胞相关的疾病,并通过照射紫外线来促进细胞凋亡。 用于预防或治疗皮肤病和皮肤癌的药物组合物含有由式(I)表示的橙胆酸或其药学上可接受的盐作为有效成分,其中药物组合物的药物作用通过照射紫外线和皮肤病增加 是增生性皮肤病,包括牛皮癣,鱼皮病,鲍文氏病,乳头状瘤,湿疹,湿疹,特应性皮炎,寻常痤疮,皮炎,扁平苔藓,条纹,足角化病,黑斑,光化性角化病,皮肤老化和光老化。